Syneos Health Trading Up 0.1 %
NASDAQ SYNH opened at $42.78 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.20 and a current ratio of 1.20. The company has a 50-day simple moving average of $42.54 and a 200-day simple moving average of $40.52. The firm has a market capitalization of $4.44 billion, a PE ratio of 62.00 and a beta of 1.58. Syneos Health has a one year low of $22.89 and a one year high of $52.23.
Syneos Health (NASDAQ:SYNH – Get Free Report) last posted its earnings results on Tuesday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.63). The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.26 billion. Syneos Health had a net margin of 1.31% and a return on equity of 8.63%. On average, equities analysts forecast that Syneos Health will post 2.79 earnings per share for the current year.
Institutional Trading of Syneos Health
About Syneos Health
Syneos Health, Inc, operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development.
- Five stocks we like better than Syneos Health
- How to Use the MarketBeat Dividend Calculator
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- The 3 Best Fintech Stocks to Buy Now
- 5 Reasons Mullen Automotive is About to Turn a Corner
- What is a Secondary Public Offering? What Investors Need to Know
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.